The AAP updated its guidance to recommend routine HIV screening at least once in all adolescents aged ≥15 years and at-risk youth be rescreened annually.
Nearly 25% of patients with HIV who use antiretroviral therapy will reach 65 years of age or older by 2030, researchers projected in a new analysis.
IDWeek 2021: Despite declining mortality rates among patients with HIV in the past 2 decades, a new study finds significant disparities in gender and race.
Viral-load monitoring rates decreased and clinic visits declined overall despite an increase in use of telehealth.
Patients with HIV had a 14% higher risk of sudden cardiac death than those without HIV, according to a large analysis of US veterans.
Rodger MacArthur, MD, was in his HIV clinic last week and queried his COVID-19 vaccine-hesitant/resistant patients about their reasons. The refrain was familiar and discouraging.
Vaccines from both companies were significantly effective against COVID-19 and show promise against variants from the UK and South Africa.
Cabotegravir and rilpivirine, injectable formulation is administered once-weekly, reducing treatment days for adults with HIV from 365 to 12.
The FDA announced October 3 approval of Descovy®, making it the second drug to receive indication for HIV pre-exposure prophylaxis.
Highlights: The first liquid solution of colchicine for prophylaxis of gout, the first generic version of Advair Diskus, and 8 more new and approved drugs.